Sinotherapeutics Inc. (688247.SH) forecasts a pre-increase, with an expected net profit of 115 million to 138 million yuan in 2024, a year-on-year growth of 89% to 127%.

Sinotherapeutics Inc. (688247.SH) announced that the company expects to achieve a net profit attributable to the owners of the parent company of 115 million to 138 million yuan in 2024, an increase of 54.34 million to 77.41 million yuan compared to the same period last year, a year-on-year increase of 89% to 127%.